Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-SA 4.0Journal of Clinical and Experimental Hematopathology : JCEH

A case of bone marrow–liver–spleen type diffuse large B-cell lymphoma: importance of rapid diagnosis and therapeutic intervention

  1. 1Department of Hematology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan, Department of Pathology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan

Abstract

Bone marrow–liver–spleen (BLS)-type diffuse large B-cell lymphoma (DLBCL) is a rare and aggressive variant characterized by primary involvement of the bone marrow, liver, and spleen without lymphadenopathy. We describe the case of a 73-year-old woman who presented with multiorgan failure complicated by disseminated intravascular coagulation and clinical features suggestive of secondary hemophagocytic lymphohistiocytosis. Prompt initiation of intensive chemotherapy (R-CHOP: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone) guided by characteristic clinical findings including bone marrow smear examination, resulted in rapid clinical improvement and prolonged survival.

Rather than representing an unusual diagnostic dilemma, this case illustrates a clinically characteristic and educational presentation of BLS-type DLBCL and highlights the importance of timely lymphoma-directed treatment based on readily available hematologic evidence.

Related

  1. Viral states and immune competence in Epstein–Barr virus-positive diffuse large B-cell lymphoma: conditions for therapeutic targeting
    Xinzhu Tang, Qiuhui Wu, He Li +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  2. Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B-cell lymphoma: Molecular mechanisms and therapeutic implications (Review)
    Chuanyang Lu, Tingting Zhou, Wenxin Zhang +5
    International Journal of OncologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  3. MUTATIONAL PROFILE OF DIFFUSE LARGE B-CELL LYMPHOMA DETECTED IN CIRCULATING TUMOR DNA AT DIAGNOSIS
    Thiago ELEUTÉRIO GONÇALVES, Flavia SACILOTTO DONAIRES, Bárbara Amélia APARECIDA SANTANA +5
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  4. Intelligent Hydrogel Sensors for Health Monitoring and Therapeutic Intervention: From Material Design to Integrated Diagnosis and Treatment.
    Di Chu, Qi Hou, Mingxin Li +1
    Gels (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Nasopharyngeal diffuse large b-cell lymphoma in a teenage presenting with cavernous sinus syndrome: A case report
    Radiology case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{eda2026case,
  title = {{A case of bone marrow–liver–spleen type diffuse large B-cell lymphoma: importance of rapid diagnosis and therapeutic intervention}},
  author = {Hitomi Eda and Kaoru Furihata and Fumiya Ogasawara},
  journal = {Journal of Clinical and Experimental Hematopathology : JCEH},
  year = {2026},
  month = jul,
  doi = {10.3960/jslrt.26011},
  url = {https://doi.org/10.3960/jslrt.26011},
  note = {CC BY-NC-SA 4.0},
}
RIS
TY  - JOUR
TI  - A case of bone marrow–liver–spleen type diffuse large B-cell lymphoma: importance of rapid diagnosis and therapeutic intervention
AU  - Hitomi Eda
AU  - Kaoru Furihata
AU  - Fumiya Ogasawara
PY  - 2026
DA  - 2026/07/30
JO  - Journal of Clinical and Experimental Hematopathology : JCEH
DO  - 10.3960/jslrt.26011
UR  - https://doi.org/10.3960/jslrt.26011
AB  - Bone marrow–liver–spleen (BLS)-type diffuse large B-cell lymphoma (DLBCL) is a rare and aggressive variant characterized by primary involvement of the bone marrow, liver, and spleen without lymphadenopathy. We describe the case of a 73-year-old woman who presented with multiorgan failure complicated by disseminated intravascular coagulation and clinical features suggestive of secondary hemophagocytic lymphohistiocytosis. Prompt initiation of intensive chemotherapy (R-CHOP: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone) guided by characteristic clinical findings including bone marrow smear examination, resulted in rapid clinical improvement and prolonged survival.  Rather than representing an unusual diagnostic dilemma, this case illustrates a clinically characteristic and educational presentation of BLS-type DLBCL and highlights the importance of timely lymphoma-directed treatment based on readily available hematologic evidence.
SN  - 1346-4280
SN  - 1880-9952
ER  -